Evaluation of Hepatitis C Viral Load Quantification on DBS in Vietnam
MOVIDA-Hep
Improving Access to Viral Load Monitoring in HIV-infected Patients on ART in Decentralised Area Using Dried Blood Spot : Evaluation of Hepatitis C Viral Load Quantification on DBS
1 other identifier
interventional
315
1 country
2
Brief Summary
In Vietnam, the prevalence of hepatitis C virus (HCV) infection is estimated between 0.4% and 5%, which is much higher than the prevalence in Europe or in the USA. After HCV diagnosis, HCV viral load quantification is crucial in order to distinguish recovered from active (on-going) HCV infection and hence identify those who need antiviral treatment to cure HCV infection. HCV viral load quantification is also important to assess treatment efficacy. Currently, anti-HCV antibodies detection is available around the country. However, access to confirmation of HCV viremia remains scarce particularly in decentralized areas. One of the reason is the limited number of laboratories able to perform this complex biological measurement; moreover, these laboratories are situated only in large urban centres. Blood sampling using DBS could help overcome this difficulty of access to a laboratory, and widen access to HCV viral load monitoring. The present MOVIDA Hep study aims at validating the use of DBS to measure HCV viral load as compared to plasma (gold standard). A secondary objective is to evaluate the measurement of HCV core antigen on DBS. For this, 315 patients need to be enrolled form outpatient clinics in Hanoi. The laboratory in charge of these measurements would be the virology laboratory of the National Institute of Hygiene and Epidemiology (NIHE) in Hanoi (Vietnam).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2019
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 10, 2018
CompletedFirst Posted
Study publicly available on registry
September 13, 2018
CompletedStudy Start
First participant enrolled
May 9, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 11, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 11, 2019
CompletedApril 1, 2022
February 1, 2020
2 months
September 10, 2018
March 21, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Quantification of HCV RNA on DBS compared to plasma as gold standard
Sensitivity and specificity of HCV RNA VL measured on DBS collected by venipuncture
Up to 4 weeks
Secondary Outcomes (6)
Quantification of HCV RNA measured on DBS using plasma as gold standard
Up to 4 weeks
Correlation between HCV RNA VL measured on DBS and on plasma.
Up to 6 months
Quantification of HCV core antigen using HCV RNA VL as gold standard
Up to 8 weeks
Correlation between HCV core antigen and HCV RNA VL on plasma
Up to 6 months
Quantification of HCV core antigen measured on DBS using HCV RNA VL measured on plasma as gold standard.
Up to 8 weeks
- +1 more secondary outcomes
Study Arms (1)
Blood sampling
OTHERblood samples from venepuncture (10mL) and from fingertip (approximatively 0.4mL) on a dried blood spots
Interventions
Blood sample of 10 mL by venipuncture and 0,4 mL by finger prick
Eligibility Criteria
You may qualify if:
- ≥18 years of age
- Known HCV infection
- Willing to participate to the study by giving his/her consent.
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Institut Pasteurlead
- National Institute of Hygiene and Epidemiology, Vietnamcollaborator
- Hanoi University of Public Healthcollaborator
Study Sites (2)
Dong Da Hospital
Hanoi, Vietnam
Nam Tu Liem Hospital
Hanoi, Vietnam
Related Publications (4)
Taieb F, Tran Hong T, Ho HT, Nguyen Thanh B, Pham Phuong T, Viet Ta D, Le Thi Hong N, Ba Pham H, Nguyen LTH, Nguyen HT, Nguyen TT, Tuaillon E, Delaporte E, Le Thi H, Tran Thi Bich H, Nguyen TA, Madec Y. First field evaluation of the optimized CE marked Abbott protocol for HIV RNA testing on dried blood spot in a routine clinical setting in Vietnam. PLoS One. 2018 Feb 9;13(2):e0191920. doi: 10.1371/journal.pone.0191920. eCollection 2018.
PMID: 29425216BACKGROUNDTaieb F, Tram TH, Ho HT, Pham VA, Nguyen L, Pham BH, Tong LA, Tuaillon E, Delaporte E, Nguyen AT, Bui DD, Do N, Madec Y. Evaluation of Two Techniques for Viral Load Monitoring Using Dried Blood Spot in Routine Practice in Vietnam (French National Agency for AIDS and Hepatitis Research 12338). Open Forum Infect Dis. 2016 Jul 7;3(3):ofw142. doi: 10.1093/ofid/ofw142. eCollection 2016 Sep.
PMID: 27704001BACKGROUNDSoulier A, Poiteau L, Rosa I, Hezode C, Roudot-Thoraval F, Pawlotsky JM, Chevaliez S. Dried Blood Spots: A Tool to Ensure Broad Access to Hepatitis C Screening, Diagnosis, and Treatment Monitoring. J Infect Dis. 2016 Apr 1;213(7):1087-95. doi: 10.1093/infdis/jiv423. Epub 2015 Sep 2.
PMID: 26333945BACKGROUNDTran TH, Nguyen BT, Nguyen TA, Pham TTP, Nguyen TTT, Mai HTB, Pham HB, Nguyen TM, Phan HTT, Do NT, Ait-Ahmed M, Taieb F, Madec Y. Dried blood spots perform well to identify patients with active HCV infection in Vietnam. J Viral Hepat. 2020 May;27(5):514-519. doi: 10.1111/jvh.13263. Epub 2020 Feb 11.
PMID: 31981287RESULT
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Fabien TAIEB, MD, PhD, MPH
Institut Pasteur
- PRINCIPAL INVESTIGATOR
Tuan Anh NGUYEN, MD, PhD
National Institute of Hygiene and Epidemiology (NIHE)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 10, 2018
First Posted
September 13, 2018
Study Start
May 9, 2019
Primary Completion
July 11, 2019
Study Completion
July 11, 2019
Last Updated
April 1, 2022
Record last verified: 2020-02
Data Sharing
- IPD Sharing
- Will not share